ConductScience.org, home

Paper119583

Comparative metabolism and excretion of adriamycin in man, monkey, and rat.

Wilkinson PM and 3 others. Cancer Chemother Pharmacol, 1979. Cited by 47 papers, by iCite.

11 sourcespapers-2026-11-12-0.1.0

Download JSON
Cite this record

ConductScience Library. Comparative metabolism and excretion of adriamycin in man, monkey, and rat. Papers, record 119583. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/119583

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Comparative metabolism and excretion of adriamycin in man, monkey, and rat.
PubMed
Journal
Cancer Chemother Pharmacol
PubMed
Year
1979
PubMed
Publication types
Comparative Study, Journal Article, Research Support, U.S. Gov't, P.H.S.
PubMed
Citations, by iCite
47
iCite
Relative citation ratio, by iCite
2.61
iCite
Revised in PubMed
2019-08-27
PubMed

Authors4

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Wilkinson PMP M
2Israel MM
3Pegg WJW J
4Frei E 3rdE

Source PubMed

Topics13

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
DoxorubicinMajor topic
Animals
Bile
Biotransformation
Female
Haplorhini
Humans
Kinetics
Macaca fascicularis
Male
Rats
Species Specificity
Time Factors

Source PubMed

References19

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
14,106,507Analysis of the pharmacokinetic characteristics, pharmacological and chemotherapeutic activity of 14-Hydroxy-daunomycin (Adriamycin), a new drug endowed with an antitumour activity.Arzneimittelforschung1971https://conductscience.org/library/papers/4106507PubMed
24,723,268Pharmacokinetics and metabolism of adriamycin in man.Clin Pharmacol Ther1973https://conductscience.org/library/papers/4723268PubMed
35,075,698Distribution and metabolism of daunomycin, adriamycin, and N-acetyldaunomycin in the Syrian golden hamster.Biochem Med1972https://conductscience.org/library/papers/5075698PubMed
43,405Adriamycin metabolism in man. Evidence from urinary metabolites.Drug Metab Dispos1976https://conductscience.org/library/papers/3405PubMed
55,081,602Daunorubicin metabolism in acute nonlymphocytic leukemia.Clin Pharmacol Ther1972https://conductscience.org/library/papers/5081602PubMed
64,417,723Adriamycin and daunorubicin disposition in the rabbit.J Pharmacol Exp Ther1974https://conductscience.org/library/papers/4417723PubMed
74,593,553Distribution of daunomycin and adriamycin in mice. A comparative study.Biomedicine1973https://conductscience.org/library/papers/4593553PubMed
84,694,357Daunorubicin biliary excretion and metabolism in the rat.Arch Int Pharmacodyn Ther1973https://conductscience.org/library/papers/4694357PubMed
9884,924Bilary disposition of adriamycin.Clin Pharmacol Ther1977https://conductscience.org/library/papers/884924PubMed
10620,407Hepatobiliary metabolism and excretion of adriamycin and N-trifluoroacetyladriamycin-14-valerate in the rat.Cancer Res1978https://conductscience.org/library/papers/620407PubMed
11633,073Urinary anthracycline metabolites from mice treated with adriamycin and N-trifluoroacetyladriamycin-14-valerate.J Pharmacol Exp Ther1978https://conductscience.org/library/papers/633073PubMed
121,137,589Adriamycin and metabolites: separation by high-pressure liquid chromatography and quantitation by radioimmunoassay.Biochem Med1975https://conductscience.org/library/papers/1137589PubMed
1322,454,955The persistence of adriamycin in man and rat.Br J Clin Pharmacol1974https://conductscience.org/library/papers/22454955PubMed
145,073,307Plasma and urinary levels of adriamycin in man.Eur J Cancer (1965)1972https://conductscience.org/library/papers/5073307PubMed
15911,624Hepatobiliary metabolism and excretion of adriamycin (ADR) in man [proceedings].Br J Clin Pharmacol1977https://conductscience.org/library/papers/911624PubMed
165,030,818Comparative pharmacokinetics of daunomycin and adriamycin in several animal species.Cancer Res1972https://conductscience.org/library/papers/5030818PubMed
171,054,622N-trifluoroacetyladriamycin-14-valerate, an analog with greater experimental antitumor activity and less toxicity than adriamycin.Cancer Res1975https://conductscience.org/library/papers/1054622PubMed
181,175,172Preliminary pharmacokinetic model for adriamycin (NSC-123127).Cancer Chemother Rep1975https://conductscience.org/library/papers/1175172PubMed
194,590,654Adriamycin. A new anticancer drug with significant clinical activity.Ann Intern Med1974https://conductscience.org/library/papers/4590654PubMed

Cited by12

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 47 citations.

PMIDTitleJournalYearIn PapersSource
7,334,460Development and identification of a multicompartment model for the distribution of adriamycin in the rat.J Pharmacokinet Biopharm1981https://conductscience.org/library/papers/7334460PubMed
6,940,622Different distribution of adriamycin in normal and leukaemic rats.Br J Cancer1981https://conductscience.org/library/papers/6940622PubMed
6,840,177Doxorubicin and 5-fluorouracil plasma concentrations and detectability in parotid saliva.Eur J Clin Pharmacol1983https://conductscience.org/library/papers/6840177PubMed
6,819,097Effect of cyclophosphamide pretreatment on the short-term disposition and biliary excretion of adriamycin metabolites in rat.Cancer Chemother Pharmacol1982https://conductscience.org/library/papers/6819097PubMed
6,584,234Disposition of 14C-labelled 4'-epidoxorubicin and doxorubicin in the rat. A comparative study.Cancer Chemother Pharmacol1984https://conductscience.org/library/papers/6584234PubMed
6,189,661Clinical pharmacokinetics of commonly used anticancer drugs.Clin Pharmacokinet1983https://conductscience.org/library/papers/6189661PubMed
3,770,010Hepatic metabolism of doxorubicin in mice and rats.Eur J Drug Metab Pharmacokinet1986https://conductscience.org/library/papers/3770010PubMed
3,753,554Comparative pharmacokinetics and metabolism of doxorubicin and 4-demethoxy-4'-O-methyldoxorubicin in tumor-bearing mice.Cancer Chemother Pharmacol1986https://conductscience.org/library/papers/3753554PubMed
3,581,417Hepatic extraction, metabolism and biliary excretion of doxorubicin in the isolated perfused rat liver.Cancer Chemother Pharmacol1987https://conductscience.org/library/papers/3581417PubMed
3,520,474Anthracycline antitumour agents. A review of physicochemical, analytical and stability properties.Pharm Weekbl Sci1986https://conductscience.org/library/papers/3520474PubMed
3,476,219Metabolism of epidoxorubicin in animals: absence of glucuronidation.Cancer Chemother Pharmacol1987https://conductscience.org/library/papers/3476219PubMed
1,628,370Doxorubicin and doxorubicinol plasma concentrations and excretion in parotid saliva.Cancer Chemother Pharmacol1992https://conductscience.org/library/papers/1628370PubMed

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/119583

GET https://conductscience.org/api/papers/v1/119583/authors